What is Zimmer Biomet Holdings, Inc.'s stock symbol? What are your Zimmer Biomet Holdings, Inc. (ZBH) stock predictions? What is Zimmer Biomet Holdings, Inc. (ZBH)'s dividend history? How much is Zimmer Biomet Holdings, Inc. (ZBH)'s dividend? What were Zimmer Biomet Holdings, Inc.'...
Dividend 0.24 USD Ex-Div Date 2025-03-31 Yield 0.853 Div. Freq. QZBH CompetitorsNewsProfileAnalyst Coverage5 Yr. FinancialsDividendsEarningsPrice HistoryEventsInsiders Zimmer Biomet Holdings Inc. News Stock Investing News, Analysis and Tips Nov 15, 2024 2:56 PM EST Stocks lower Friday. Movers:...
SCHD Schwab Us Dividend Equity Etf $27.44 -0.30 -1.08% VOO Vanguard S&P 500 Etf $513.76 +2.48 +0.49% MINT Pimco Enhanced Short Maturity Active Exchange-Traded Fund $100.44 +0.01 +0.01% Trending Stocks Data as of Mar 13, 2025 TSLA Tesla, Inc. Common Stock $248.09 +17.51 +7.59% ...
ZBH Stock USD 106.91 1.49 1.37% Zimmer Biomet math operators tool provides the execution environment for running the Price Series Summation operator and other technical functions against Zimmer Biomet. Zimmer Biomet value trend is the prevailing direction of the price over some defined period of time...
Dividend & Yield About Zimmer Biomet Holdings Inc CEO Ivan Tornos, Jr., MBA Number Of Employees 17,000 Sector Health Technology Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, ex...
Microsoft Corporation Common Stock $387.82 +4.30+1.12% Trending ETFs Data as of May 24, 2025 QQQ Invesco Qqq Trust, Series 1 $480.89 +6.35+1.34% SPY Spdr S&P 500 $567.13 +6.11+1.09% SCHD Schwab Us Dividend Equity Etf $28.03 +0.11+0.39% ...
Dividend $0.24 Ex-Dividend Date Mar 31, 2025 Short Interest 6.22M 03/14/25 % of Float Shorted 3.13% Average Volume 1.88M Performance 5 Day -2.21% 1 Month 2.82% 3 Month 2.87% YTD 4.50% 1 Year -13.68% Analyst Ratings Sell Under Hold Over Buy Number of Ratings 32 Full Ratings...
Stock Price Assets Cash and Equivalent Cost of Sales Current Assets Current Liabilities Debt Dividend Yield EBIT EBITDA Employees EPS Earnings Per Share Equity Capital and Reserves Gross Profit on Sales Interest Expense on Debt Loan Capital Market Capitalization Net Income Ope...
Stock Price Assets Cash and Equivalent Cost of Sales Current Assets Current Liabilities Debt Dividend Yield EBIT EBITDA Employees EPS Earnings Per Share Equity Capital and Reserves Gross Profit on Sales Interest Expense on Debt Loan Capital Market Capitalization Net Income Ope...
Overall, any bad news from the decline in profits looks to be priced into the stock. The forward P/E has fallen to 10, or nearly half the earnings multiple for the market as a whole. McKesson has historically traded at a premium P/E to the market. ...